Nitric Acid Market It Is Expected To Witness A CAGR Of 1.8% From 2015 To 2022: Grand View Research, Inc.

The global nitric acid market size is expected to reach USD 14.0 billion by 2022, according to a new report by Grand View Research, Inc., progressing at a CAGR of 1.8% during the forecast period. Flourishing agriculture industry and surging demand for fertilizers are among the key trends escalating market growth.

Growing need for high yield in order to meet demands of ever-rising population is creating an upswing in the use of synthetic fertilizers, which is anticipated to have a positive impact on the market. Growth in chemical processing industry, particularly in developing countries including China and India, is likely to further fuel the demand for nitric acid.

Ammonium nitrate fertilizer is estimated to be the largest application segment throughout the forecast period due to increasing demand from the agriculture sector coupled with lack of regulations regarding use of nitrate-based fertilizers in some developing countries.

Asia Pacific was the leading market for nitric acid in 2013 on account of strong presence of the chemical and fertilizer industries in the region. Stringent regulations in Europe and North America pertaining to the use of synthetic fertilizers have resulted in shift of demand to emerging economies such as China and India. Central & South American countries, including Mexico and Brazil, are also projected to have strong growth prospects in light of increasing number of chemical companies.

Spiraling demand for food and favorable government initiatives are leading to rapid expansion in the agriculture industry in India, China, and Brazil, which in turn is poised to stoke the growth of the market. Rising demand for bio-based fertilizers owing to increasing environmental concerns is projected to have a negative impact on the market. However, high demand for ammonium nitrate as a fertilizer will continue to keep the growth of the nitric acid market strong.

View summary of this report @ www.grandviewresearch.com/industry-analysis/nitric-acid-market

Further Key Findings from the Report Suggest:

  • In terms of revenue, the fertilizers application is anticipated to reach USD 11,257.7 million by 2022, at a CAGR of 1.8% from 2015 to 2022
  • In terms of revenue, Toulene di-isocynate application is projected to grow at a CAGR of 2.6% over the forecast period
  • Adipic acid held 3.7% of the global market in 2015 and is expected to reach 3.9% by 2022
  • The North America nitric acid market is anticipated to reach USD 1,811.7 million by 2022
  • Asia Pacific is projected to witness a CAGR of 2.8% over the forecast period, owing to rapid developments in the agriculture sector
  • Some of the key companies present in the market are DuPont; BASF; The Dow Chemical Company; Agrium Inc.; Omnia Holdings; Apache Nitrogen Products Inc.; and CF.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/agrochemicals-and-fertilizers

Grand View Research has segmented the global nitric acid market report on the basis of application and region:

Nitric Acid Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2022)

  • Fertilizers
  • Adipic Acid
  • Nitrobenzene
  • Toulene di-isocynate
  • Nitrochlorobenzene
  • Others

Nitric Acid Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2022)

  • North America
    • U.S.
  • Western Europe
    • Germany
  • Central & Eastern Europe
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Oceania
  • Latin America
    • Brazil
  • Middle East & Africa
    • Saudi Arabia
    • Qatar

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Info: www.grandviewresearch.com

 

Advertisements

Liquid Crystal Polymers (LCP) Market Is Expected To Grow At A CAGR Of 8.6% From 2014 To 2020: Grand View Research, Inc.

Global Liquid Crystal Polymers (LCP) Market is expected to reach USD 1.23 billion by 2020, according to a new study by Grand View Research, Inc. Shift in trend towards miniaturization of electrical components such as surface mount device and connectors is expected to drive global LCP market. Growing demand for lightweight, high performance materials from automotive industry in order to improve fuel efficiency is also expected to have a positive influence on the market growth. Lower welding strength and warpage associated with LCP is expected to remain a key challenge for market participants.

Electrical & electronics emerged as the leading application segment and accounted for 81.5% of total market volume in 2013. Growing engineering resins demand for manufacturing ultra-thin electrical components is expected to remain a key driving factor for this segment. LCP is favored over other engineering resins such as polyphenylene sulfide (PPS), nylon 46 and polyphthalamide (PPA) which has further propelled market growth. Electrical & electronics is also expected to witness the highest growth rate of 8.9% over the forecast period. LCP demand from automotive industry is expected to grow at an estimated CAGR of 7.3% from 2014 to 2020. Shift in trend towards adoption of lightweight, high performance materials from automotive industry particularly in the U.S. and Europe is expected to drive this segment.

View summary of this report @ www.grandviewresearch.com/industry-analysis/liquid-crystal-polymers-market

Further key findings from the study suggest:

  • Global LCP demand was 46.1 kilo tons in 2013 and is expected to reach 81.7 kilo tons by 2020, growing at a CAGR of 8.6% from 2014 to 2020.
  • China was the leading regional market and accounted for 46.1% of total market volume in 2013. China is expected to continue its dominance over the forecast period owing to rapid expansion of electronics & electrical industry in the nation. Other Asian countries such as India, Japan, South Korea and Taiwan are also expected to witness steady growth over the forecast period.
  • Industrial machinery applications include ceramic material substitutes and mass transfer packaging in chemical industries. Increasing industrial machinery demand particularly in China and other Asian countries is expected to complement regional market growth.
  • North American LCP market is expected to reach USD 241.4 million by 2020, growing at an estimated CAGR of 7.3% from 2014 to 2020.
  • Global LCP market is highly consolidated with top four companies accounting for over three-fourth of total market. Some major companies operating in the global LCP market include Celanese Corporation, Polyplastics Co., Ltd, Solvay S.A and Sumitomo Chemical. Other companies include Toray International, Inc, Samsung Fine Chemicals and Ueno Fine Chemicals Industry Ltd.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/specialty-bio-based-and-water-soluble-polymers

Grand View Research has segmented the LCP market on the basis of application and region:

Global Liquid Crystal Polymer (LCP) Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2020)

  • Electrical & Electronics
  • Industrial Machinery
  • Automotive
  • Others

Global Liquid Crystal Polymer (LCP) Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 – 2020)

  • North America
  • Europe
  • China
  • Rest of Asia Pacific

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Info: www.grandviewresearch.com

 

Population Health Management Market Is Expected To Reach USD 88.9 Billion By 2025: Grand View Research, Inc.

The global population health management market is expected to reach USD 88.9 billion by 2025, according to a new report by Grand View Research, Inc. The need for population health services that combine multiple functionalities is increasing, due to the complex nature of care delivery and payment models. PHM solutions can process clinical, financial, and operational data for the improvement of efficiency and patient care. Convenience offered by value-based payment models is responsible for increased adoption of population health solutions by the accountable care organizations (ACOs).

ACOs, consisting of hospitals, clinics, doctors, and other caregivers, collaborate with the payers for the delivery of high quality care to the patients. Private and public insurance providers have introduced various disease management programs, to assist in treatment of chronic illnesses. These multidisciplinary efforts are expected to result in efficient treatment outcomes and are likely to suggest best suitable courses of action that need to be undertaken. Successful large-scale trials in the U.S. have enabled significant advancements in disease management programs.

View summary of this report @ www.grandviewresearch.com/industry-analysis/population-health-management-phm-market

Further Key Findings From The Report Suggest:

  • Population health management has changed focus from fee-for-service to value-based payments.
  • Based on the applications, the PHM market is grouped into software and services. Of these the software segment held the majority of the market share in the year 2016, as it offers higher level of customizations based on business needs.
  • PHM software offer on premise benefits and data analytics network to manage multiple functionalities of healthcare in single platform.
  • PHM software offers predictive data analytics, which can be applied for interpreting population characteristics from unstructured clinical data.
  • Healthcare providers held the largest market share of the end-use segment in the market in year 2016.
  • With the help of PHM solutions, the providers can focus effectively on patient-centric care and reducing overall costs
  • North America was the largest PHM market in 2016 and is likely to retain its position over the forecast period, as the providers, payers, providers-payers, and accountable care organizations promote the use of PHM services.
  • Asia Pacific is expected to witness the fastest growth in the coming years due to rising healthcare expenditure and improving healthcare infrastructure in the region.
  • Allscripts, McKesson Corporation, Cerner Corporation, etc. are some of the key market players. Some of the strategic initiatives undertaken by these companies to strengthen their market presence include acquisitions and partnerships with other market players.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the population health management market based on application, end-use and region:

Application Outlook (Revenue, USD Million; 2014 – 2025)

  • Software
  • Services

End-Use Outlook (Revenue, USD Million; 2014 – 2025)

  • Payers
  • Providers
  • Employer Groups

Regional Outlook (Revenue, USD Million; 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Info: www.grandviewresearch.com

 

Hormonal Contraceptive Market It Is Projected To Experience A CAGR Of 4.0% From 2018 To 2025: Grand View Research, Inc.

The global hormonal contraceptive market size is expected to reach USD 26.2 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 4.0% during the forecast period. Introduction of innovative products in the market and growing awareness about reproductive and sexual health in emerging regions are likely to drive the market in the coming years.

Pill, Intrauterine Devices (IUD), injectable, vaginal rings, implants, and patches are various methods used for hormonal contraception. Hormonal contraception methods act on the endocrine system to prevent ovulation.

Increasing number of women in developing economies are using contraceptives due to rise in government initiatives and programs, which is anticipated to accelerate market growth. For instance, according to the UN, approximately 64.0% of women between 15 and 49 years of age were using some form of family planning in 2015, be it traditional or modern. This figure stood at 36.0% in 1970.

The number of unintended pregnancies annually is highest in U.S., which is about 3 million. Hence, the Center for Medicaid and CHIP Services (CMCS) established a Maternal and Infant Health Initiative for the Medicaid and Children’s Health Insurance Program (CHIP) program to promote use of effective methods of contraception and help women avoid such pregnancies.

View summary of this report @ www.grandviewresearch.com/industry-analysis/hormonal-contraceptive-market

Further key findings from the report suggest:

  • Increasing demand for contraceptive methods can be attributed to growing awareness about pills and devices, increasing significance of family planning, and supportive government regulations improving access to these products
  • In 2016, pills accounted for the largest share in the market as they are convenient to use and exhibit more than 99.0% effectivity when accurately consumed. Furthermore, ease of availability, fewer adverse effects, and large number of players operating in the market can be attributed to this share
  • The IUD segment is expected to witness the fastest growth during the forecast period. This can be attributed to entry of new devices in the market over the recent past, availability of long-acting reversible birth control methods, and more than 99.0% effectivity
  • Geographically, North America held the largest share in 2016 and is anticipated to maintain its dominance during the forecast period due to local presence of market players, high per capita income, and supportive government initiatives
  • Asia Pacific is estimated to witness the fastest growth during the forecast period due to high unmet need, expected increase in coverage during the next 15 years, and increasing number of women of reproductive age
  • Some of the key players operating in the market are Teva Pharmaceuticals Industries Ltd.; Bayer AG, Merck & Co. Inc.; Pfizer, Afaxys, Inc.; Agile Therapeutics; Allergan; and Apothecus Pharmaceutical Corporation.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the global hormonal contraceptive market on the basis of method and region:

Hormonal Contraceptive Method Outlook (Revenue, USD Million, 2014 – 2025)

  • Pill
  • Intrauterine Devices (IUD)
  • Injectable
  • Vaginal Ring
  • Implant
  • Patch

Hormonal Contraceptive Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Info: www.grandviewresearch.com

 

Varicose Vein Treatment Market Forecast Worth $475 Million By 2024: Grand View Research, Inc.

The global varicose vein treatment market is expected to reach USD 475 million by 2024, according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market.

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market.

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.  

View summary of this report @ www.grandviewresearch.com/industry-analysis/varicose-vein-treatment-devices-market

Further key findings from the report suggest:

  • In 2015, the sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.
  • The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segmenthas gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.
  • In 2015, the endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.
  • In 2016, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region
  • As of 2016, Europe is characterized by a shift towards less-invasive procedures in treating large varicose veins. It is expected to witness a high growth rate over the forecast period due to the favorable government initiatives and advanced treatment procedures.
  • The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income
  • Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.
  • AngioDynamics, Inc. and MerzPharma GmbH & Co. KGaAin North America established a multi-year relationship to market Asclera for patients with peripheral vascular diseases.In the U.S,.MerzPharma GmbH & Co. KGaAserves as the exclusive distributor of the Asclera Injection. Asclera is approved for the treatment of spider and reticular veins, which showed good improvement in 95% of the patients treated with asclera.
  • In 2016, Medtronic plc acquired Italian hemodialysis player Bellco, Inc.This acquisition is projected to enable the medical device giant to gain market position in newly formed renal care solution business.
  • In 2015, Medtronic plc acquired Covidien plc with the objective to move into the additional therapeutic areas, such as chronic venous insufficiency. Covidien plc markets the Venefit procedure that uses radiofrequency energy and minimally invasive radiofrequency ablation to treat the disease.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global varicose vein treatment market on the basis of procedures, devices,and regions:

Varicose Vein Treatment Outlook ByType (Revenue, USD Million, 2013 – 2024)

  • Sclerotherapy
  • Endovenous Ablation
    • Laser Ablation
    • Radiofrequency Ablation
  • Stripping

Varicose Vein Treatment Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • MEA
    • South Africa
    • Rest of MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Info: www.grandviewresearch.com

 

Industrial Air Filtration Market Size Was Estimated At USD 3.38 Billion In 2015 And Is Expected To Reach $6.08 Billion By 2025: Grand View Research, Inc.

The global industrial air filtration market is expected to reach USD 6.08 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for high-performing, energy-efficient products is expected to catapult the demand over the forecast period. Further, environmental awareness and rapid industrialization coupled with resource scarcity are also expected to catalyze the market growth over the next nine years. Technological advancements have resulted in the manufacturing of a new filter media to meet the demand of energy-efficient products. This, in turn, has instigated the development of innovative raw materials such as small fibers and is anticipated to provide new avenues for industry growth.

Financial drivers are also expected to play key roles in incentivizing end-users to enhance the performance of a manufacturing process and reduce manufacturing costs. The industry is anticipated to witness the movement of manufacturing facilities to China or Eastern Europe, primarily, to cut-down manufacturing costs.Industrial air filters are critical components of the manufacturing industry as they are used to protect sensitive and advanced manufacturing processes and reduce the risk of molecular or microbiological contaminations. They also eliminate hazardous emissions in several manufacturing processes and are expected to witness a healthy demand in the European market, owing to a spate of regulations governing these industries.

View summary of this report @ www.grandviewresearch.com/industry-analysis/industrial-air-filtration-market

Further key findings from the report suggest:

  • Dust collectors accounted for over 20% of the overall market in 2015, owing to their widespread usage in industrial applications, primarily, in controlling air pollution
  • The demand for filters in the power segment accounted for over 10% of the overall revenue in 2015 and the segment is expected to witness a steady growth over the next nine years, as power generation industries have numerous filter requirements, such as increasing effectiveness and efficiency, for environment protection.
  • Asia Pacific accounted for over 20% of the overall revenue in 2015 and is expected to witness a substantial growth over the forecast period, which is accredited to the high penetration of these products across the metals industry to support several regulatory requirements
  • Key players, such as Donaldson Company, Clarcor, Inc., Cummins Filtration, and Camfil, enhanced their market position through mergers & acquisitions and expanded their geographical reach

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/hvac-and-construction-technologies

Grand View Research has segmented the global industrial air filtration market based on product, end-use, and region:

Industrial Air Filtration Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Dust Collectors
  • Mist Collectors
  • HEPA Filters
  • Cartridge Collectors & Filters
  • Baghouse Filters

Industrial Air Filtration End-use Outlook (Revenue, USD Million, 2014 – 2025)

  • Cement
  • Food
  • Metals
  • Power
  • Pharmaceuticals
  • Agriculture
  • Woodworking and Paper & Pulp
  • Plastic
  • Others

Industrial Air Filtration Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Turkey
    • Sweden
    • Spain
    • Poland
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Info: www.grandviewresearch.com

 

Medical Sensors Market Will Grow Rapidly Based On Rising Prevalence Of Chronic Conditions Such As Diabetes And Hypertension Till 2024: Grand View Research, Inc.

The medical sensors market is expected to reach USD 18.5 billion by 2024, according to a new report by Grand View Research, Incite upsurge in the number of patients afflicted with chronic conditions, such as diabetes and hypertension, is fueling the usage of monitoring as well therapeutic devices, thus boosting the market demand.

The target population for this market is patients with chronic illnesses, as such conditions necessitate regular checkups and intermittent or continuous patient monitoring. The rise in population of chronically ill patients further increases the uptake of the medical sensors.

The geriatric population is highly prone to developing chronic disorders and they pose a higher risk of developing age-related deformities and complications. Moreover, the adoption of unhealthy food habits and sedentary lifestyles and the resultant surge in the incidence of obesity has led to the increasing prevalence of lifestyle disorders including diabetes. The presence of a large target population base combined with the prevalence of lifestyle-related risk factors is likely to accelerate the growth of the medical sensors market during the forecast period.

Technological advancements in terms of accuracy, portability, and affordability associated with the new generation medical sensors resulted in the increased usage of these devices; for instance, the introduction of easy-to-operate, home-based diagnostic kits that are cost effective.

View summary of this report @ www.grandviewresearch.com/industry-analysis/medical-sensors-market

Further key findings from the study suggest: 

  • The biosensors products segment held a lucrative share of over 40.0% in 2015. This is ascribable to the following attributes of the novel biosensors: durability, reliability, and accuracy. Moreover, their applications in the healthcare areas, such as the detection of drug abuse, glucose monitoring for diabetes, the detection of cholesterol, and others. All these elements governed the growth of this segment in 2015.
  • The surgical applications of the sensors dominated the market in 2015. Whereas, the monitoring applications segment is projected to be the fastest growing during the forecast period. Advancements, such as wearable technology are anticipated to boost the demand for the monitoring devices market.
  • The hospitals registered a remunerative growth in 2015; this can be attributed to the presence of a well-developed healthcare infrastructure, which yields faster and accurate diagnosis. Moreover, the availability of well-equipped infrastructure coupled with the presence of skilled personnel and technologically advanced equipments contribute towards the lucrative growth of this segment.
  • North America held a considerably large share of over 35.0% in 2015 owing to the presence of leading sensor manufacturers, a well-planned medical reimbursement network, and the increasing disposable income
  • On the contrary, Asia Pacific is anticipated to be the fastest growing region with a CAGR of over8.0% over the forecast period. The favorable economic developments and the advancing healthcare system with the aid of supportive government initiatives are anticipated to further assist the growth. Moreover, the increasing base of the aging population in this region also, additionally impels the demand. According to the report published by the Ministry of Statistics, in India, 8.6% of the total population is aged above 60; hence, presenting a profitable opportunity for the market players to invest in this region.
  • The leading players of the medical sensors market include Analog devices, Inc., Avago technologies Ltd., Danaher Corporation, GE Measurement &Control Solutions, Inc., Honeywell International, Inc., Stellar technologies, Inc., OmniVision Technologies, Inc., Sensation AG, TE Connectivity Ltd., Micro-Epsilon Messtechnik GmbH Co. & KG, and NXP Semiconductors N.V.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the medical sensors market on the basis of product, application area, end-use, and region.

Global Medical Sensors Market, by Product, Revenue(USD Million) 2013 – 2024

  • Pressure sensors
  • Temperature sensors
  • Image sensors
  • Accelerometers
  • Biosensors
    • Cholesterol sensors
    • Blood glucose sensors
    • Pregnancy testing
    • Drug discovery
    • Infectious diseases
    • Others
  • Flow sensors
  • SQUID sensors
  • Others

Global Medical Sensors Market, by Application, Revenue(USD Million), 2013 – 2024

  • Surgical
  • Diagnostic
  • Therapeutic
  • Monitoring
  • Others

Global Medical Sensors Market, by End-use, Revenue(USD Million), 2013 – 2024

  • Hospitals
  • Physician offices
  • Nursing home
  • Home healthcare
  • Others

Medical Sensors Market, by Region, Revenue, (USD Million), 2013 – 2024

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
    • Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Info: www.grandviewresearch.com

 

Autonomous Cars Market Demand To Reach 138,089 Units By 2024: Grand View Research, Inc.

The global autonomous cars market is expected to reach 138,089 units by 2024, according to a new study by Grand View Research, Inc. The growing acceptance of semi-autonomous technologies, such as Adaptive Cruise Control (ACC), automatic parking, and forward collision avoidance, is anticipated to pave the way for the adoption of driverless automobiles over the next seven years. An upsurge in the demand for increased comfort and convenience, particularly in countries with an aging population, is expected to propel the driverless vehicles demand over the forecast period.

Features offered by the driverless cars primarily include a considerable decline in the frequency of road accidents caused due to human errors and easy commute. The self-driving technology exhibits a huge potential, owing to its capability to improve on-road safety, lower the energy consumption, and reduce congestion. Autonomous cars offer enhanced safety and efficiency over the conventional automobiles. Furthermore, driverless cars are anticipated to substantially impact the energy usage and reduce pollution. Autonomous vehicles can improve the fuel economy by accelerating & decelerating more effortlessly as compared to human drivers.

On the other hand, the high price of driverless vehicles may act as a hindrance for the market growth. The emotional implication of giving over personal safety and accountability to a machine may result in volatile public responses toward errors. The liability in case of accidents poses a key challenge for the government to address in advance to the adoption of autonomous cars. In addition to this, the penetration of driverless vehicles in taxis and other private point-to-point traveling industries is expected to increase the unemployment rate of drivers. Thus, the driverless vehicles are anticipated to witness mixed views. However, the increasing government support across the developed countries is expected to encourage the adoption of autonomous cars during the forecast period.

View summary of this report @ www.grandviewresearch.com/industry-analysis/driverless-cars-market

Further key findings from the study suggest:

  • North America is anticipated to dominate the market with over 40% of the volume share in 2017.The region is further anticipated to witness a considerable growth over the next seven years. This growth is primarily attributed to the growing acceptance of the self-driving cars on the public roads of the U.S. Alphabet Inc. is the first company to demonstrate the prototype in the U.S. and has been testing its automobiles in different weather conditions since 2009. Furthermore, the growing government support in amending the current policy to accommodate the driverless feature in automobiles is expected to clear gateway for its adoption.
  • Asia Pacific is expected to witness a sluggish growth as compared to North America and Europe. However, it is anticipated to grow substantially in the later phase of the forecast period due to the growing adoption of technologically advanced cars in China. In addition, the Japanese government has specifically laid down a plan for the successful self-driving vehicle deployment and is expected to catapult the product demand over the forecast period.
  • For the initial adoption, the manufacturers are anticipated to target countries which have a lower population, including Singapore, the Netherlands, and Sweden, to better analyze the response toward the acceptance of the technology before deploying it in countries with a larger potential. This is ascribed to be a key factor for the considerable growth in the aforementioned countries. Furthermore, the Singaporean government has also proposed to build separate roads for driverless automobiles to accelerate the adoption.
  • Europe is a key region for the deployment of self-driving vehicles, owing to the high consumer preference for technologically advanced products. This region is estimated to hold more than 35% of the volume share in 2017. This is attributed to the presence of players such as Volvo, Volkswagen, PSA Peugeot Citroën, and Fiat Chrysler Automobiles in Germany and the UK. The European countries also focus on reducing pollution.
  • The prominent industry participants include Apple Inc., Baidu Inc., Alphabet Inc., Tesla Motors, Inc., The Volvo Group, and Nissan Motor Company Ltd. The system developers focus on collaborating with the Body in White (BIW) providers to reduce the additional cost.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/automotive-and-transportation

Grand View Research has segmented the global autonomous cars/driverless cars market on the basis of region:

Autonomous Cars Regional Outlook (Units; 2017 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Netherlands
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • Australia
    • Singapore
  • Latin America
  • Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Info: www.grandviewresearch.com

 

Thalassemia Market To Gain From Rising Demand For Improved Curative Gene Therapies Till 2022: Grand View Research, Inc.

The global thalassemia market size is expected to be valued at USD 3.53 billion by 2022, as per a new report by Grand View Research, Inc., exhibiting a CAGR of 10.8% during the forecast period. Increase in demand for a universal cure, rise in awareness about the disease, and technological advancements are likely to increase the adoption of gene therapies.

Thalassemia is a general term for a group of inheritable blood disorders, in which the body produces abnormal hemoglobin, resulting in destruction of red blood cells. This ultimately leads to anemia. There are two main types of thalassemia: alpha-thalassemia and beta-thalassemia, the latter being more serious. Beta-thalassemia is a common autosomal recessive disorder worldwide and it is relatively rare in U.S.

Increase in incidence of thalassemia is anticipated to fuel market growth. Despite technological advancements, unmet need for a reliable treatment option still exists. Treatment of thalassemia is mostly restricted to regular blood transfusions and iron chelation therapy. Drugs prescribed for thalassemia mostly cure symptoms and side effects such as anemia, iron overload, and vitamin deficiency. However, gene therapy is emerging as a reliable treatment option for the disease.

Prevalence of thalassemia is reported to increase gradually over the years across different regions. This can be attributed to population migration, intermarriages, and genetic and environmental factors prompting the condition and its implications.

View summary of this report @ www.grandviewresearch.com/industry-analysis/thalassemia-market

Further key findings from the report suggest: 

  • The global thalassemia market is expected to expand at a lucrative CAGR of 10.8% over the forecast period because of improved safety and efficacy profiles of gene therapy
  • India and Thailand are expected to offer lucrative growth opportunities for market expansion
  • Some of the key players in the industry with promising pipeline products are bluebird bio, Inc.; Acceleron Pharma; Novartis AG; Incyte Corporation; Kiadis Pharma; Gamida Cell; and Celgene Corporation
  • Blood transfusion and iron chelation therapies were the preferred treatment options for thalassemia in 2016, owing to their higher usage, ease, and affordability. However, the segments are likely to lose market share over the forecast period due to increase in adoption of curative gene therapy
  • Regionally, among the seven major markets, EU5 held the dominant share in terms of revenue in 2016, followed by U.S. and Japan
  • S. is expected to be the fastest growing region with a lucrative CAGR from 2016 to 2022 due to increase in prevalence of the disease and presence of well-established healthcare services

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global thalassemia market based on therapeutic class, pipeline, and region:

Thalassemia Therapeutic Class Outlook (Revenue, USD Million, 2016 – 2022)

  • Iron Chelating Drugs
    • Exjade/Jadenu (deferasirox)

Pipeline Outlook (Revenue, USD Million, 2016 – 2022)

  • Gene Therapy
    • LentiGlobin

Regional Outlook (Revenue, USD Million, 2016 – 2022)

  • U.S.
  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Japan

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Info: www.grandviewresearch.com

 

Liquid Handling Technology Market Size Worth $6.99 Billion By 2025: Grand View Research, Inc.

The global liquid handling technology market size is estimated to reach USD 6.99 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 8.5% during the forecast period. Rising competition in the pharmaceutical sector, demand for precision and acceleration in laboratory workflow, and increased investment in drug discovery and clinical research are anticipated to boost market growth.

High wages of skilled employees have encouraged research centers and pharmaceutical players to automate their processing activities. Higher accuracy levels offered by novel liquid handling workstations eliminate human errors and provide rapid results. Reduction in cost by avoiding excess use of expensive reagents, less workforce employment, and time advantage gained have influenced adoption of high throughput fully automated liquid handlers.

Though high purchase as well as maintenance cost, along with complex operability, limits adoption on a wider scale, large biopharmaceutical players anticipate integration in the coming years. Groundbreaking innovations such as Next Generation Sequencing (NGS) have revolutionized the pace of research and drug target screening. Need for advanced liquid handling technology to support simultaneous screening of multiple assays and samples further fuels market demand.

Lucrative revenue generation in the market is attributive to swift adoption of advanced products along with high volume sales of consumables and small devices. Key players have strategic collaborations with universities and research centers to support their liquid handling needs. Acquisition of emerging players in different geographies to expand their market share is anticipated to increase competition in this market.

View summary of this report @ www.grandviewresearch.com/industry-analysis/liquid-handling-technology-market

Further key findings from the study suggest:

  • Consumables accounted for the largest share in market revenue in 2016 owing to low cost and high penetration globally. Automated workstations, on the other hand, are poised to register the fastest growth owing to increased scale of research and higher pricing
  • Semi-automated liquid handling is expected to witness lucrative growth in developing countries such as South Africa. Increasing significance of CROs in healthcare and pharmaceutical research is anticipated to drive growth
  • Drug discovery and ADME-Tox research are estimated to account for the largest share in terms of revenue. This can be attributed to high competition and need to gain time advantage over competitors.
  • Rapid adoption of technological advances, rising pay of highly skilled professionals, and presence of dominant players have contributed to North America’s large share in 2016. However, Asia Pacific is poised to witness fastest growth over the forecast period owing to rising interest of global investors in the region
  • Rapid economic developments in countries in APAC have resulted in growing investments in life science, medicine, and pharmaceutical sectors. Progress in these sectors is anticipated to propel demand for liquid handling technology at various levels, from low-to-high throughput applications
  • Key players operating in this industry include Agilent Technologies; Aurora Biomed Inc.; Beckman Coulter, Inc.; Analytik Jena AG; BioTek Instruments, Inc.; Borosil Glass Works Ltd.; Labnet International, Inc.; Eppendorf AG; Gilson, Inc.; Hamilton Company; LABCYTE INC.; and Tecan Trading AG. Major players are involved in development of novel technology platforms to support changing liquid handling needs of high-end users.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global liquid handling technology market on the basis of product, type, application, end user, and region:

Liquid Handling Technology Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Automated Workstations
  • Small Devices
    • Pipettes
      • Electronic Pipettes
      • Manual Pipettes
      • Pipette Controllers
    • Burettes
    • Dispensers
    • Others
  • Consumables
    • Regents
    • Disposable Tips
    • Tubes & Plates
    • Others

Liquid Handling Technology Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Automated Liquid Handling
  • Manual Liquid Handling
  • Semi-Automated Liquid Handling

Liquid Handling Technology Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Drug Discovery & ADME-Tox Research
  • Cancer & Genomic Research
  • Bioprocessing/Biotechnology
  • Others

Liquid Handling Technology End User Outlook (Revenue, USD Million, 2014 – 2025)

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organization

Liquid Handling Technology Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
  • MEA
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For More Info: www.grandviewresearch.com